Liver metastases developed 5 months later and following disease progression on dacarbazine (1000 mg/m2, two cycles), given that a KIT p.L576P mutation was present in the primary tumour biopsy, imatinib was administered (400 mg/day). This evidence concerns the gene KIT and neoplasm.